Document ID: chunk:federal_register_of_legislation:F2025L00049:schedule:6:p36
Version: federal_register_of_legislation:F2025L00049
Segment Type: schedule
Provision Reference: sch 6 (pt 36/36)
Character Range: 412828–414419

for human therapeutic use; or

       (b) in preparations containing 5% or less of trinitrophenol.
    TRISODIUM NITRILOTRIACETATE except in preparations containing 20% or less of trisodium nitrilotriacetate.
    VAMIDOTHION.
    VINYL ACETATE MONOMER (excluding its derivatives) except:

       (a) in preparations for therapeutic use; or

       (b) in cosmetic preparations containing 0.01% or less of vinyl acetate as residual monomer in a polymer; or

       (c) in other preparations containing 1% or less of vinyl acetate.
    WARFARIN except when included in Schedule 4 or 5.
    XYLENE (excluding its derivatives) except in preparations containing 50% or less of xylene or xylene and toluene.
    ZERANOL in ear implants for use as a growth promotant in steer cattle.
    ZETA‑CYPERMETHRIN in preparations containing 10% or less of zeta‑cypermethrin.
    ZINC BORATE (excluding its derivatives) for use as an agricultural chemical.
    ZINC CHLORIDE except:

       (a) when included in Schedule 2; or

       (b) in preparations containing 5% or less of zinc chloride.
    ZINC para‑PHENOLSULFONATE except in preparations containing 5% or less of zinc para‑phenolsulfonate.
    ZINC LACTATE in toothpaste except in toothpaste preparations containing 2.5% or less of zinc lactate and labelled with the statement:

        Not recommended for children under twelve years of age.
    ZINC SULFATE except:

       (a) when included in or expressly excluded from Schedule 4; or

       (b) in other preparations containing 5% or less of zinc sulfate.
    ZIRAM in granular preparations.